This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Humer, J. Articles by Pehamberger, H. Search for Related Content PubMed PubMed Citation Articles by Humer, J. Articles by Pehamberger, H.

Identification of a Melanoma Marker Derived from Melanoma-Associated Endogenous Retroviruses

Departments of ¹ Dermatology, Division of General Dermatology and ² Surgery; and ³ Clinic for Blood Group Serology and Transfusion Medicine, Medical University of Vienna; ⁴ Green Hills Biotechnology GmbH; ⁵ Emergentec Biodevelopment GmbH, Vienna, Austria; and ⁶ Paul-Ehrlich-Institut, Langen, Germany

Requests for reprints: Thomas Muster, Green Hills Biotechnology GmbH, Gersthoferstrasse 29-31, 1180 Vienna, Austria. Phone: 43-1-3199670; Fax: 43-1-3196099; E-mail: t.muster{at}greenhillsbiotech.com.

We previously described the expression of melanoma-associated endogenous retrovirus (MERV) proteins and viral particles in human melanomas and metastases. The objective of the present study was to determine whether a humoral immune response to MERV proteins occurs in melanoma. Candidate B-cell epitopes on MERV proteins were predicted using bioinformatic screening. The reactivity of MERV peptides corresponding to the predicted epitopes with antibodies prevalent in sera of melanoma patients was analyzed. An immunodominant peptide located in the env protein of MERV was identified. Subsequent analyzes using 81 samples from stage I to stage IV melanoma patients and 95 sera from healthy subjects revealed statistically significant differences in seroprevalence of antibodies in melanoma sera samples when compared with reference samples from healthy subjects. The prevalence of anti-MERV antibodies in melanoma patient sera was confirmed by immunofluorescence on env-transfected cells. These data indicate the potential of this candidate peptide as target for diagnosis and immunotherapy. (Cancer Res 2006; 66(3): 1658-63)

This article has been cited by other articles:

				C. Voisset, R. A. Weiss, and D. J. Griffiths Human RNA "Rumor" Viruses: the Search for Novel Human Retroviruses in Chronic Disease Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 157 - 196. [Abstract] [Full Text] [PDF]